X2A7358
Assistance Coronary Sinus to New Technology Group 8 with Intermittent Coronary Sinus Occlusion, Percutaneous Approach
Procedural Specifications
| Clinical Axis | Detail Definition |
|---|---|
| Section | X New Technology |
| Body System | 2 Cardiovascular System |
| Operation | A Assistance |
| Body Part | 7 Coronary Sinus |
| Approach | 3 Percutaneous |
| Device | 5 Intermittent Coronary Sinus Occlusion |
| Qualifier | 8 New Technology Group 8 |
Operation Definition
Taking over a portion of a physiological function by extracorporeal means
Procedure Overview
This family covers temporary mechanical circulatory support devices that take over a portion of the heart's pumping function from outside the body, used when a patient's own heart can't adequately maintain blood flow on its own. Typical scenarios include cardiogenic shock, a heart attack complicated by pump failure, or high-risk procedures like complex angioplasty where a patient needs hemodynamic backup while the underlying problem is treated or the heart recovers.
Unlike devices that fully replace heart function, these systems are designed to assist rather than substitute for the heart entirely, buying time for recovery, bridging a patient to a more definitive treatment, or supporting them through a procedure that would otherwise put too much strain on a failing heart.
Anatomy & Axis Detail
Coronary Sinus
The coronary sinus is the main venous channel draining deoxygenated blood from the heart muscle into the right atrium, and its consistent anatomy makes it a convenient conduit for catheter-based access to the coronary venous system. Assistance directed at the coronary sinus typically involves a catheter seated within it to temporarily support or augment myocardial perfusion, such as delivering pressure-controlled retroperfusion or supersaturated oxygenated blood to jeopardized heart muscle after an acute ischemic event or during high-risk intervention. Because the vessel is thin-walled and variably sized, positioning is done under fluoroscopic or venographic guidance to avoid dissection, and the support is physiologic augmentation rather than removal of tissue or permanent device placement, distinguishing it from pacing lead or annuloplasty procedures that also use this route.
Approach: Percutaneous
In New Technology, Percutaneous describes entry into the body via needle or instrument puncture through the skin or a mucous membrane, without a surgical incision, mirroring the same concept in Medical and Surgical. It is distinguished from Open access, which requires a full incision, and from Percutaneous Endoscopic, which adds visualization through the puncture site.
Device / Substance / Technology: Intermittent Coronary Sinus Occlusion
This value denotes a device that periodically narrows the coronary sinus to raise pressure within the coronary venous system, redistributing blood flow toward ischemic myocardium in patients with refractory angina. Its intermittent, adjustable narrowing sets it apart from fixed reduction devices that create a permanent, unchanging constriction. The approach is a therapeutic rather than diagnostic intervention aimed at symptom relief.
Qualifier: New Technology Group 8
Group 8 identifies technologies added to the New Technology section for the 2021-2022 update cycle, tying a given code to that specific approval year. The underlying substance, device, or technique is defined by the other six axis positions, not by the group number itself. Because group numbers simply track chronology, Group 8 differs from Group 7 and Group 9 only in when CMS granted the technology separate recognition.
Coding & Documentation
Accurate coding requires the record to specify the exact device and its qualifier, since different circulatory assist devices are distinguished by design and the way they interact with the heart's own output. Duration of support and the vessel or chamber accessed for device placement also matter for complete documentation. A frequent mistake is coding this as Performance, which applies when a device completely takes over a function, rather than Assistance, which applies when the device supplements a heart that is still contributing some of its own pumping.
Commonly Confused With
This family is commonly confused with Performance procedures such as cardiopulmonary bypass, where the device fully replaces cardiac or respiratory function rather than assisting it. The distinction turns on whether the native heart continues to contribute to circulation alongside the device, which points to Assistance, or whether the device has completely taken over, which points to Performance.